Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila Markwardt

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of General Internal Medicine|March 1, 2019
Diabetes-Multimorbidity Combinations and Disability Among Middle-aged and Older AdultsAna R Quiñones, Sheila Markwardt, Anda Botoseneanu
Substance Abuse Treatment, Prevention, and Policy|February 1, 2022
The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon: a cohort studyTracy A Klein, Daniel Hartung, Sheila Markwardt
Gerontology|March 1, 2023
Multimorbidity and Functional Disability among Older Adults: The Role of Inflammation and Glycemic Status - An Observational Longitudinal StudyAnda Botoseneanu, Sheila Markwardt, Ana R Quiñones
Neurology. Clinical Practice|January 8, 2025
Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare ProgramDaniel M Hartung, Sheila Markwardt, Dennis Bourdette
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 17, 2018
Using Skype to Beat the Blues: Longitudinal Data from a National Representative SampleAlan R Teo, Sheila Markwardt, Ladson Hinton
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 13, 2016
Multimorbidity Combinations and Disability in Older AdultsAna R Quiñones, Sheila Markwardt, Anda Botoseneanu
Pediatric Pulmonology|December 8, 2020
Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbationsCorinne A Muirhead, Natalie Lanocha, Sheila Markwardt, et al.
Clinical Therapeutics|December 4, 2014
Changes in long-acting β-agonist utilization after the FDA's 2010 drug safety communicationDaniel M Hartung, Luke Middleton, Sheila Markwardt, et al.
Health Affairs (Project Hope)|February 5, 2019
Trends In Coverage For Disease-Modifying Therapies For Multiple Sclerosis In Medicare Part DDaniel M Hartung, Kirbee A Johnston, Adriane Irwin, et al.
Frontiers in Pediatrics|September 8, 2025
The effect of modulators on lung function following inpatient treatment for CF exacerbationsAnne Stone, Meredith B Haag, Corinne A Muirhead, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of General Internal Medicine|March 1, 2019
Diabetes-Multimorbidity Combinations and Disability Among Middle-aged and Older AdultsAna R Quiñones, Sheila Markwardt, Anda Botoseneanu
Substance Abuse Treatment, Prevention, and Policy|February 1, 2022
The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon: a cohort studyTracy A Klein, Daniel Hartung, Sheila Markwardt
Gerontology|March 1, 2023
Multimorbidity and Functional Disability among Older Adults: The Role of Inflammation and Glycemic Status - An Observational Longitudinal StudyAnda Botoseneanu, Sheila Markwardt, Ana R Quiñones
Neurology. Clinical Practice|January 8, 2025
Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare ProgramDaniel M Hartung, Sheila Markwardt, Dennis Bourdette
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 17, 2018
Using Skype to Beat the Blues: Longitudinal Data from a National Representative SampleAlan R Teo, Sheila Markwardt, Ladson Hinton
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 13, 2016
Multimorbidity Combinations and Disability in Older AdultsAna R Quiñones, Sheila Markwardt, Anda Botoseneanu
Pediatric Pulmonology|December 8, 2020
Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbationsCorinne A Muirhead, Natalie Lanocha, Sheila Markwardt, et al.
Clinical Therapeutics|December 4, 2014
Changes in long-acting β-agonist utilization after the FDA's 2010 drug safety communicationDaniel M Hartung, Luke Middleton, Sheila Markwardt, et al.
Health Affairs (Project Hope)|February 5, 2019
Trends In Coverage For Disease-Modifying Therapies For Multiple Sclerosis In Medicare Part DDaniel M Hartung, Kirbee A Johnston, Adriane Irwin, et al.
Frontiers in Pediatrics|September 8, 2025
The effect of modulators on lung function following inpatient treatment for CF exacerbationsAnne Stone, Meredith B Haag, Corinne A Muirhead, et al.
Pageof 4